Systolic blood pressure and cardiovascular mortality among 13,740 Dutch women

Preventive Medicine
A M van der GiezenH J Collette

Abstract

Prospective data of cardiovascular mortality in relation to the systolic blood pressure of women are scarce, especially when combined with other risk factors. The association between systolic blood pressure and cardiovascular mortality was therefore studied in a 10-year follow-up of a population of 13,740 Dutch women, born between 1911 and 1925 who participated in a population-based breast cancer screening project (the DOM Project). Age-adjusted mortality rates over the 10-year follow-up period suggest a J-shaped pattern of cardiovascular mortality according to level of systolic blood pressure. Age-adjusted total cardiovascular, coronary, and cerebrovascular mortality rate ratios were significantly greater than 1.0 among women with elevated systolic blood pressure. Within categories of other risk factors (obesity index, diabetes mellitus, current smoking, and use of antihypertensive medicines) the age-adjusted cardiovascular rate ratios did not show confounding by any of these variables. A very high increase in cardiovascular mortality was observed among hypertensive diabetic women. This study shows that elevated systolic blood pressure is associated with increased rates of cardiovascular mortality for women in this age group.

References

Nov 1, 1977·British Heart Journal·L WilhelmsenH Wedel
Jun 1, 1978·Journal of Epidemiology and Community Health·I HjermannP Leren
Dec 1, 1976·International Journal of Epidemiology·T GordonW B Kannel
Mar 14, 1987·Lancet·J M CruickshankF J Zacharias
May 16, 1987·Lancet·J M CruickshankF J Zacharias
May 16, 1987·Lancet·G Berglund, O Samuelsson
Jun 13, 1987·Lancet·J Coope, T S Warrender
Dec 1, 1987·Journal of Epidemiology and Community Health·J G Evans
Nov 19, 1987·The New England Journal of Medicine·W C WillettC H Hennekens
Dec 5, 1986·JAMA : the Journal of the American Medical Association·E BloomC MacLean
Jul 1, 1985·Circulation·E Barrett-Connor, K T Khaw
Jul 1, 1974·Progress in Cardiovascular Diseases·W B Kannel
May 1, 1974·American Journal of Public Health·A M OstfeldH M Tufo
Jan 1, 1984·Journal of Chronic Diseases·E Barrett-ConnorD L Wingard
Jan 1, 1984·Journal of Chronic Diseases·F de WaardC Honing
Jul 1, 1980·Preventive Medicine·M H CriquiJ D Turner

❮ Previous
Next ❯

Citations

Jun 27, 2002·The American Journal of Cardiology·Sandra J Lewis
Mar 27, 2001·Journal of the American College of Cardiology·A M Dart, B A Kingwell
Aug 22, 2003·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Harry A J Struijker BoudierMichel E Safar
Jan 31, 2003·The Journal of Clinical Hypertension·A lice A Furumoto-DawsonHenry R Black
May 1, 2009·Maturitas·Karin Schenck-Gustafsson
Dec 1, 1991·Baillière's Clinical Obstetrics and Gynaecology·T L Bush, K Miller-Bass
Jan 27, 2016·Circulation·Laxmi S MehtaUNKNOWN American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Card
Apr 23, 2004·Journal of Human Hypertension·H SchellemanW M M Verschuren
Aug 7, 2017·Current Treatment Options in Cardiovascular Medicine·Marysia S TweetSharonne N Hayes
Apr 3, 2008·Menopause International·Margaret ReesUNKNOWN British Menopause Society Council

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.